Aromatherapy Effects on Multiple Sclerosis

Not Applicable

Recruiting

• Conditions: Multiple sclerosis.; Demyelinating diseases of the central nervous system; G35-G37

• Registration Number: IRCT20180103038211N8
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All patients with MS who have Expanded Disability Status Scale (EDSS) equal or less than 4.
Patients with MS aged 18 to 50 years old
Informed consent

Exclusion Criteria

Use of other complementary and alternative methods during the study
Sleeping and sedative medications, antidepressants and analgesics during the study
History of asthma or respiratory diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality with Pittsburgh Sleep Quality Questionnaire. Timepoint: Measurement of sleep quality at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Fatigue with Fatigue Impact Scale MS. Timepoint: Measurement of fatigue at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: Fatigue Impact Scale MS.;Anxiety with State-Trait Anxiety Inventory (STAI). Timepoint: Measurement of anxiety at the beginning of the study and the end of the fourth week after the intervention began. Method of measurement: State-Trait Anxiety Inventory (STAI).